D. Ding et al. / Tetrahedron Letters 47 (2006) 6997–6999
Table 2. Preparation of 2-aryl-4-quinolones (Scheme 2)
6999
Entry
R
Ar
Time (min)
Yielda (%)
Mp (°C)
Ref.
a
b
c
d
e
H
H
H
H
H
H
H
Phenyl
10
10
10
10
10
10
12
10
10
10
10
22
18
10
10
10
85
67
81
81
63
69
74
87
64
79
73
57
63
84
65
95
251–253
252–254
292–294
234–235
232–234
282–284
>300
>300
>300
>300
>300
271–273
286–289
216–218
257–260
213–216
3b
3b
6
4-Chlorophenyl
4-Methoxyphenyl
2-Methoxyphenyl
3,4,5-Trimethoxyphenyl
4-Chloro-3-pyridyl
2-Thiophene
—
3b
—
—
3c
—
—
—
—
—
4c
—
—
f
g
h
i
j
k
l
m
n
o
p
4-Chloro
4-Chloro
4-Chloro
4-Chloro
4,5-Dimethoxy
4,5-Dimethoxy
3,4,5-Trimethoxy
3,4,5-Trimethoxy
3,4,5-Trimethoxy
Phenyl
4-Chlorophenyl
4-Methoxyphenyl
2-Thiophene
4-Methoxyphenyl
2-Thiophene
Phenyl
4-Chlorophenyl
4-Methoxyphenyl
a Isolated yields.
containing a magnetic stirring bar was charged with
compound 1p (107.4 mg, 0.3 mmol), NaOH (60 mg,
1.5 mmol) and 1.5 mL t-BuOH. The vial was sealed and
the resulting suspension was heated in the Biotage Initiator
Synthesizer under selected microwave conditions. The
conversion was monitored by HPLC and the product
analyzed by LC–MS. The reaction mixture was cooled and
poured onto 8 mL of water and adjusted to pH 5–6. The
solution was concentrated under reduced pressure until
copious solid appeared. The solid was collected and washed
successively with water and a cold mixture of acetone and
dichloromethane to give the pure product.
provided an opportunity to acquire many other
analogues.
Acknowledgements
This work was financially supported by the National
Natural Science Foundation of China (Grant
30230400).
8. All products were characterized by NMR, MS, and IR
spectroscopy. The following spectral data are representa-
tive: Compound 2d: white solid; yield 81%; mp: 234–235 °C.
1H NMR (400 MHz, DMSO-d6): d = 3.90 (s, 3H), 7.23–
7.26 (m, 1H), 7.29 (s, 1H), 7.34–7.36 (m, 1H), 7.67–7.71 (m,
2H), 7.76–7.80 (m, 1H), 8.03–8.07 (m, 1H), 8.14–8.16 (m,
1H), 8.34–8.36 (m, 1H); IR (KBr): 3425, 2941, 1639, 1599,
References and notes
1. Gootz, T. D.; Brighty, K. E. Med. Res. Rev. 1996, 16, 433.
2. Xia, Y.; Yang, Z. Y.; Morris-Natschke, S. L.; Lee, K. H.
Curr. Med. Chem. 1999, 6, 179.
3. (a) Chen, B. C.; Huang, X.; Wang, J. Synthesis 1987, 482;
(b) Kasahara, A.; Izumi, T.; Watabe, H.; Takahashi, S.
Chem. Indust. 1981, 121; (c) Kuo, S. C.; Lee, H. Z.; Juang,
J. P.; Lin, Y. T.; Wu, T. S.; Chang, J. J.; Lednicer, D.;
Paull, K. D.; Lin, C. M.; Hamel, E.; Lee, K. H. J. Med.
Chem. 1993, 36, 1146.
4. (a) Li, L.; Wang, H. K.; Kuo, S. C.; Wu, T. S.; Lednicer,
D.; Lin, C. M.; Hamel, E.; Lee, K. H. J. Med. Chem. 1994,
37, 3400; (b) Xia, Y.; Yang, Z. Y.; Xia, P.; Hack, T.;
Hamel, E.; Mauger, A.; Wu, J. H.; Lee, K. H. J. Med.
Chem. 2001, 44, 3932; (c) Hadjeri, M.; Pellier, E. L.; Beney,
C.; Deka, N.; Lawson, M. A.; Dumontet, C.; Boumendjel,
A. J. Med. Chem. 2004, 47, 4964; (d) Beney, C.; Hadjeri,
M.; Mariotte, A. M. Tetrahedron Lett. 2000, 41, 7037; (e)
Gao, H.; Kawabata, J. Bioorg. Med. Chem. 2005, 13, 1661.
5. (a) Das, S. K. Synlett 2004, 915; (b) Lidstrom, P.; Tierney,
J.; Wathey, B.; Westman, J. Tetrahedron 2001, 57, 9225; (c)
Mavandadi, F.; Lidstrom, P. Curr. Top. Med. Chem. 2004,
4, 773; (d) Kappe, C. O. Angew. Chem., Int. Ed 2004, 43,
6250; (e) Yin, W.; Ma, Y.; Xu, J. X.; Zhao, Y. F. J. Org.
Chem. 2006, 71, 4312; (f) Cui, S. L.; Lin, X. F.; Wang, Y. G.
J. Org. Chem. 2005, 70, 2866; (g) Mishra, J. K.; Rao, J. K.;
Sastry, G. N.; Panda, G. Tetrahedron Lett. 2006, 47, 3357.
6. Kalinin, V. N.; Shostakovsky, M. V.; Ponomaryov, A. B.
Tetrahedron Lett. 1992, 33, 373.
1496, 1456, 1365, 1248 cmꢀ1 13C NMR (100 MHz, DMSO-
.
d6): d = 56.1, 107.2, 112.4, 119.9, 120.0, 121.0, 121.2, 123.6,
127.2, 131.1, 133.4, 134.4, 139.6, 152.4, 156.8, 170.2. MS
(EI): m/z = 251 (M+), 236, 120. HRMS (EI): m/z calcd for
C16H13NO2 [M+]: 251.0946; found: 251.0947. Compound
2o: white solid; yield 65%; mp: 257–260 °C. 1H NMR
(400 MHz, DMSO-d6): d = 3.81 (s, 3H), 3.85 (s, 3H), 3.94
(s, 3H), 6.75 (s, 1H), 7.34 (s, 1H), 7.70 (d, 2H, J = 8.0 Hz),
7.93 (d, 2H, J = 8.0 Hz). IR (KBr): 3377, 2933, 1630, 1603,
1568, 1527, 1477, 1408, 1265 cmꢀ1 13C NMR (100 MHz,
.
DMSO-d6): d = 55.8, 61.1, 61.9, 95.9, 108.4, 114.2, 128.9
(2C), 129.1 (2C), 132.5, 135.1, 138.7, 139.5, 146.2, 152.1,
156.2, 176.2. MS (EI): m/z = 347, 345 (M+), 330, 315, 302,
287, 272. HRMS (EI): m/z calcd for C18H16NClO4 [M+]:
345.0768; found: 345.0755. Compound 2p: white solid;
1
yield: 95%; mp: 213–216 °C. H NMR (400 MHz, DMSO-
d6): d = 3.81 (s, 3H), 3.85 (s, 3H), 3.86 (s, 3H), 3.94 (s, 3H),
6.73 (s, 1H), 7.17–7.20 (m, 2H), 7.38 (s, 1H), 7.86–7.89 (m,
2H). IR (KBr): 3435, 2941, 2837, 1610, 1517, 1400,
1255 cmꢀ1 13C NMR (100 MHz, DMSO-d6): d = 55.6,
.
56.2, 61.1, 62.1, 96.9, 105.0, 111.4 (2C), 114.7, 124.6, 129.3
(2C), 139.6, 140.3, 150.0, 150.7, 157.4, 161.8, 172.0. MS
(EI): m/z = 341 (M+), 326, 315, 298, 283, 268. HRMS
(EI): m/z calcd for C19H19NO5 [M+]: 341.1263; found:
341.1268.
7. General experimental procedure: The preparation of 2p is
representative for all synthesis. A 10 mL Biotage vial